Aurealis Pharma Submitted Clinical Trial Application for First-in-Human Phase 1-2A Clinical Study to German Health Authority Paul-Ehrlich-Institute (PEI)
Press Release Aurealis Pharma, a private biopharmaceutical company developing novel three-in-one combination biologics for chronic non-healing wounds and cancer announced today the successful submission of its first Clinical Trial Application to the German Health Authority Paul-Ehrlich-Institute (PEI) for the lead development candidate AUP1602-C to be studied in a first-in-human phase 1-2A clinical study as treatment […]
Aurealis Pharma to Strengthen It’s Board of Directors by Appointing Mr. Iain Buchanan, a Seasoned Biotech and Pharma Industry Executive
Press Release Aurealis Pharma, a private biopharmaceutical company developing novel three-in-one combination biologics for chronic non-healing wounds, cancer and osteoarthritis announced today that Mr. Iain Buchanan has joined the board of directors of the company as of May 16th 2018. Existing board members CSO and founder Mr. Thomas Wirth, senior life science executive, Mrs. Nora […]
Aurealis Pharma To Present at the European Wound Management Association (EWMA) Congress 2018 in Krakow, Poland, May 9th – 11th 2018
Press Release Aurealis Pharma, a private biopharmaceutical company developing novel three-in-one combination biologics for chronic non-healing wounds, cancer and osteoarthritis announced today that CMO Dirk Weber will attend and discuss the company´s progress and clinical development plans for lead development product AUP-16 indicated for chronic wounds at the European Wound Management Association congress in Krakow, […]
Aurealis Pharma To Attend The Swiss Biotech Day in Basel, May 3rd 2018
Press Release Aurealis Pharma, a private biopharmaceutical company developing novel three-in-one combination biologics for chronic non-healing wounds, cancer and osteoarthritis announced today that CEO Juha Yrjänheikki and CMO Dirk Weber will attend and discuss the company´s progress at the Swiss Biotech Day in Basel on May 3rd 2018. The Swiss Biotech Day has long become […]
Aurealis Pharma To Present at the 11th Annual European Life Sciences CEO Forum & Exhibition in Zurich, February 26-27th 2018
Press Release Aurealis Pharma, a private biopharmaceutical company developing novel three-in-one combination biologics for chronic non-healing wounds, cancer and osteoarthritis announced today that CEO Juha Yrjänheikki will attend and present the company´s progress at the 11th Annual European Life Sciences CEO Forum & Exhibition in Zurich on February 26-27th 2018. The presentation is scheduled for […]
Aurealis Pharma to Present at Swiss Nordic Bio 2018 in Zurich, February 8th 2018
Press Release Aurealis Pharma, a private biopharmaceutical company developing novel three-in-one combination biologics for chronic inflammation and cancer, announced today that CEO Juha Yrjänheikki will attend and present the company´s progress at the Swiss Nordic Bio 2018 partnering and investor event in Zurich on February 8th 2018. The presentation is scheduled for: Time: Thursday, February […]